CD34 and acute myeloid leukemia: As a result, within the leukemic CD34+ progenitor compartment, coculture with EVAML significantly reduced the proportion of ROShi GSHlo cells (mean percentage: 53.91%) compared to that in AML CD34+ cells treated with vehicle (mean percentage: 76.21%) (p < 0.01; Fig. 6b), as previously reported in Supplementary Fig. 5e, f for human cell lines (MOLM-13 and KG-1).